Literature DB >> 9423929

Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation.

C Tassorelli1, S A Joseph, G Nappi.   

Abstract

Nitroglycerin is a nitric oxide donor which induces sustained expression of Fos protein, a marker of neuronal activation, in specific neuronal groups in the central nervous system. The mechanisms which underlie nitroglycerin-induced neuronal activation are elusive at this time, although a precise role has been suggested for the pool of neurons containing nitric oxide synthase as well as for catecholaminergic and peptidergic pathways. The aim of this study was to provide further details on the central effect of nitroglycerin by means of a pharmacological manipulation of nitroglycerin-induced neuronal activation with inhibitors of the nitric oxide synthase, modulators of the sympathetic drive and mediators of pain perception. Adult male Sprague-Dawley rats received L-NGnitro-arginine methyl ester, 7-nitro-indazole, ephedrine sulfate, indomethacin, capsaicin or vehicle before the subcutaneous injection of nitroglycerin (10 mg/kg b.w.). They were sacrificed 4 hr after nitroglycerin administration and brain sections were processed for immunocytochemical visualization of Fos. All the pharmacological treatments administered before injecting nitroglycerin selectively influenced Fos expression in the different brain nuclei. The data obtained suggest that nitroglycerin-induced neuronal activation is mediated by nociceptive and barosensitive mechanisms. Nitric oxide seems to represent the most important mediator of this phenomenon. The sympathetic system and prostaglandin synthesis are also likely to be involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423929     DOI: 10.1016/s0028-3908(97)00122-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field.

Authors:  Nastaren Abad; Jens T Rosenberg; Tangi Roussel; Dillon C Grice; Michael G Harrington; Samuel C Grant
Journal:  Magn Reson Med       Date:  2017-09-17       Impact factor: 4.668

2.  Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex.

Authors:  Annamária Fejes-Szabó; Zsuzsanna Bohár; Enikő Vámos; Gábor Nagy-Grócz; Lilla Tar; Gábor Veres; Dénes Zádori; Márton Szentirmai; János Tajti; István Szatmári; Ferenc Fülöp; József Toldi; Árpád Párdutz; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2014-01-03       Impact factor: 3.575

3.  Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat.

Authors:  S Lee; C K Kim; C Rivier
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

4.  A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study.

Authors:  Gábor Veres; Annamária Fejes-Szabó; Dénes Zádori; Gábor Nagy-Grócz; Anna M László; Attila Bajtai; István Mándity; Márton Szentirmai; Zsuzsanna Bohár; Klaudia Laborc; István Szatmári; Ferenc Fülöp; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2016-09-14       Impact factor: 3.575

5.  Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.

Authors:  Cristina Tassorelli; Rosaria Greco; Giorgio Sandrini; Giuseppe Nappi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.

Authors:  S Akerman; D J Williamson; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

7.  Effects of anandamide in migraine: data from an animal model.

Authors:  Rosaria Greco; Antonina Stefania Mangione; Giorgio Sandrini; Mauro Maccarrone; Giuseppe Nappi; Cristina Tassorelli
Journal:  J Headache Pain       Date:  2011-02-18       Impact factor: 7.277

8.  Endogenous Na+, K+-ATPase inhibitors and CSF [Na+] contribute to migraine formation.

Authors:  Noah B Gross; Nastaren Abad; David Lichtstein; Shiri Taron; Lorena Aparicio; Alfred N Fonteh; Xianghong Arakaki; Robert P Cowan; Samuel C Grant; Michael G Harrington
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

Review 9.  NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data.

Authors:  Arpad Pardutz; Jean Schoenen
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.